Inactive Instrument
Quotes Celsion Corporation Nasdaq
Stocks
US15117N3052
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 09-24 | IMUNON, Inc. Presents Update On IMNN-001 Development Program For Women With Newly Diagnosed Advanced Ovarian Cancer | CI |
| 09-23 | Imunon, Inc. - Shareholder/Analyst Call |
Stock exchange
Basic data
Market Cap (USD)
5,639,460
Net sales (USD)
0
Free-Float
93.73%
Free-Float capitalization (USD)
5,285,650
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 5.64M | |
| +0.79% | -6.16% | +49.32% | +74.50% | 66.34B | |
| +0.14% | +6.80% | +11.96% | +90.84% | 52.92B | |
| +0.85% | +5.39% | +8.02% | +74.41% | 54.82B | |
| +0.74% | +2.75% | +26.31% | +45.29% | 44.09B | |
| +3.87% | +10.15% | +20.69% | +132.73% | 43.72B | |
| +7.91% | +4.30% | +263.91% | +602.72% | 42.13B | |
| -0.40% | +9.85% | +17.04% | +59.17% | 33.96B | |
| -1.30% | -0.68% | +37.15% | +7.04% | 26.17B | |
| +0.94% | +5.48% | +36.44% | +26.24% | 23.37B | |
| Average | +1.50% | +4.96% | +52.32% | +123.66% | 38.75B | |
| Weighted average by Cap. | +1.58% | +4.85% | +51.43% | +128.58% |
Historical Quotes: Celsion Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IMNN Stock
- Stock
- Quotes Celsion Corporation
Select your edition
All financial news and data tailored to specific country editions
